© 2004 by Oxford University Press
© 2004 Oxford University Press
BRIEF COMMUNICATION |
Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast Cancer
Affiliations of authors: Division of Genomic Medicine, University of Sheffield Medical School, Sheffield, U.K. (GM, MDT, MM, AC); Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, U.K. (CSH, PDPP, BAJP); Academic Surgical Oncology Unit, University of Sheffield Medical School, Sheffield, U.K. (SPB, MWRR); Saha Institute of Nuclear Physics, Calcutta, India (NPB)
Correspondence to: Angela Cox, PhD, Institute for Cancer Studies, University of Sheffield Medical School, Beech Hill Rd., Sheffield S10 2RX, U.K. (e-mail: a.cox{at}shef.ac.uk)
Apoptosis, or programmed cell death, is perturbed in many cancers. We tested the hypothesis that coding polymorphisms of the death receptor 4 (DR4), caspase-8 (CASP8), and caspase-10 (CASP10) genes might act as low-penetrance breast cancer genes. Single-nucleotide polymorphisms (SNPs) of these genes were genotyped in a series of 999 breast cancer case patients and 996 control subjects from Sheffield, U.K., and in a second, independent U.K. population of 2192 case patients and 2262 control subjects from East Anglia. In the Sheffield study, the rare H allele of CASP8, D302H, was associated with a reduced risk of breast cancer in a dose-dependent manner (Ptrend = .007). Furthermore, the CASP8 D302H association, but not that of the other CASP8 SNPs examined (T21914C, G50121A, and G50358A), was replicated in the East Anglian study. The combined adjusted odds ratios for breast cancer were 0.83 (95% confidence interval [CI] = 0.74 to 0.94) for the DH heterozygote and 0.58 (95% CI = 0.39 to 0.88) for the HH homozygote (Ptrend = .0002, adjusted for study). The reproducible, dose-dependent association of CASP8 D302H with breast cancer indicates the potential importance of inherited variation in the apoptosis pathway in breast cancer susceptibility.
Correspondence about this Article
- Re: Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast Cancer
- Bernd Frank, Justo Lorenzo Bermejo, Kari Hemminki, Rüdiger Klaes, Peter Bugert, Barbara Wappenschmidt, Rita K. Schmutzler, and Barbara Burwinkel
J Natl Cancer Inst 2005 97: 1012.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
![]() |
S. S. Yoo, J. E. Choi, W.-K. Lee, Y.-Y. Choi, S. Kam, M. J. Kim, H.-S. Jeon, E.-B. Lee, D. S. Kim, M.-H. Lee, et al. Polymorphisms in the CASPASE Genes and Survival in Patients With Early-Stage Non-Small-Cell Lung Cancer J. Clin. Oncol., December 1, 2009; 27(34): 5823 - 5829. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ji, A. Gu, F. Hu, S. Wang, J. Liang, Y. Xia, C. Lu, L. Song, G. Fu, and X. Wang Polymorphisms in cell death pathway genes are associated with altered sperm apoptosis and poor semen quality Hum. Reprod., October 1, 2009; 24(10): 2439 - 2446. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Ghavami, M Hashemi, S R Ande, B Yeganeh, W Xiao, M Eshraghi, C J Bus, K Kadkhoda, E Wiechec, A J Halayko, et al. Apoptosis and cancer: mutations within caspase genes J. Med. Genet., August 1, 2009; 46(8): 497 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Gaudet, R. L. Milne, A. Cox, N. J. Camp, E. L. Goode, M. K. Humphreys, A. M. Dunning, J. Morrison, G. G. Giles, G. Severi, et al. Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium Cancer Epidemiol. Biomarkers Prev., May 1, 2009; 18(5): 1610 - 1616. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. D. Shephard, R. Abo, S. H. Rigas, B. Frank, W.-Y. Lin, I. W. Brock, A. Shippen, S. P. Balasubramanian, M. W. R. Reed, C. R. Bartram, et al. A Breast Cancer Risk Haplotype in the Caspase-8 Gene Cancer Res., April 1, 2009; 69(7): 2724 - 2728. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wang, Z. Zhang, Y. Tian, J. Shao, and Z. Zhang A Six-Nucleotide Insertion-Deletion Polymorphism in the CASP8 Promoter Associated with Risk and Progression of Bladder Cancer Clin. Cancer Res., April 1, 2009; 15(7): 2567 - 2572. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rokavec, C. Justenhoven, W. Schroth, M. A. Istrate, S. Haas, H.-P. Fischer, C. Vollmert, T. Illig, U. Hamann, Y.-D. Ko, et al. A Novel Polymorphism in the Promoter Region of ERBB4 Is Associated with Breast and Colorectal Cancer Risk Clin. Cancer Res., December 15, 2007; 13(24): 7506 - 7514. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Sigurdson, P. Bhatti, M. M. Doody, M. Hauptmann, L. Bowen, S. L. Simon, R. M. Weinstock, M. S. Linet, M. Rosenstein, M. Stovall, et al. Polymorphisms in Apoptosis- and Proliferation-Related Genes, Ionizing Radiation Exposure, and Risk of Breast Cancer among U.S. Radiologic Technologists Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2000 - 2007. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rajaraman, S. S. Wang, N. Rothman, M. M. Brown, P. M. Black, H. A. Fine, J. S. Loeffler, R. G. Selker, W. R. Shapiro, S. J. Chanock, et al. Polymorphisms in Apoptosis and Cell Cycle Control Genes and Risk of Brain Tumors in Adults Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1655 - 1661. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Lan, T. Zheng, S. Chanock, Y. Zhang, M. Shen, S. S. Wang, S. I. Berndt, S. H. Zahm, T. R. Holford, B. Leaderer, et al. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma Carcinogenesis, April 1, 2007; 28(4): 823 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
The Breast Cancer Association Consortium Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. J Natl Cancer Inst, October 4, 2006; 98(19): 1382 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhivotovsky and S. Orrenius Carcinogenesis and apoptosis: paradigms and paradoxes Carcinogenesis, October 1, 2006; 27(10): 1939 - 1945. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frank, K. Hemminki, B. Wappenschmidt, A. Meindl, R. Klaes, R. K. Schmutzler, P. Bugert, M. Untch, C. R. Bartram, and B. Burwinkel Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant Carcinogenesis, March 1, 2006; 27(3): 606 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frank, K. Hemminki, K. S. Shanmugam, A. Meindl, R. Klaes, R. K. Schmutzler, B. Wappenschmidt, M. Untch, P. Bugert, C. R. Bartram, et al. Association of death receptor 4 haplotype 626C-683C with an increased breast cancer risk Carcinogenesis, November 1, 2005; 26(11): 1975 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Frank, J. L. Bermejo, K. Hemminki, R. Klaes, P. Bugert, B. Wappenschmidt, R. K. Schmutzler, and B. Burwinkel Re: Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast Cancer J Natl Cancer Inst, July 6, 2005; 97(13): 1012 - 1012. [Full Text] [PDF] |
||||
![]() |
A. Cox and G. MacPherson RESPONSE: Re: Association of a Common Variant of the CASP8 Gene With Reduced Risk of Breast Cancer J Natl Cancer Inst, July 6, 2005; 97(13): 1012 - 1013. [Full Text] [PDF] |
||||







